Occipital nerve stimulation for chronic migraine: a randomized trial

Area of Science:

• Neurology
• Neurosurgery
• Pain Management

Background:

• Chronic migraine (CM) and medication overuse headache (MOH) are disabling neurological conditions often inadequately managed by conservative treatments.
• Occipital nerve stimulation (ONS) presents an innovative therapeutic option for refractory headache disorders.

Purpose of the Study:

• To evaluate the safety and efficacy of ONS in patients diagnosed with CM and MOH.
• To assess the impact of ONS on patient disability, quality of life, and medication consumption.

Main Methods:

• A prospective, randomized cross-over study design was employed.
• Patients underwent ONS implantation after a successful stimulation trial and were randomized to "Stimulation On" or "Stimulation Off" groups.
• Outcomes including disability (MIDAS), quality of life (SF-36), and drug intake were monitored over a one-year follow-up period.

Main Results:

• Headache intensity and frequency were significantly reduced when ONS was active compared to when it was off (p < 0.05).
• Patients experienced significant improvements in disability scores (MIDAS A and B, p < 0.001) and quality of life (p < 0.05) over one year.
• Medication use for triptans and NSAIDs decreased dramatically, from 20 and 25.5 doses/month at baseline to 3 and 2 doses/month at one year, respectively (p < 0.001).
• Five adverse events were reported: 2 infections and 3 lead migrations.

Conclusions:

• Occipital nerve stimulation (ONS) demonstrates safety and efficacy for carefully selected patients with chronic migraine and medication overuse headache.
• ONS offers a promising alternative for managing debilitating headache conditions refractory to conventional therapies.